Update on CSF Biomarkers in Parkinson’s Disease
Update on CSF Biomarkers in Parkinson’s Disease
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Progress in developing disease-modifying therapies in Parkinson’s disease (PD) can only be achieved through reliable objective markers that help to identify subjects at risk. This includes an early and accurate diagnosis as well as continuous monitoring of disease progression and therapy response. Although PD diagnosis still relies mainly on clinic...
Alternative Titles
Full title
Update on CSF Biomarkers in Parkinson’s Disease
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_846aae21cfdf46d39c07793552b171d1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_846aae21cfdf46d39c07793552b171d1
Other Identifiers
ISSN
2218-273X
E-ISSN
2218-273X
DOI
10.3390/biom12020329
